OS
OncoSil Medical Ltd
OSL.AX · ASX
$1.09 +19.23% (+$0.18)
1M -24.79%
Market Cap $28.1M
P/E Ratio -
Div. Yield -
ROE 211.94%
Piotroski F-Score Moderate
4/9Valuation
15 /100
Expensive P/B 5.63x
P/S 16.68x
PEG N/A
Growth
78 /100
Growing Book val. growth 20.33%
Rev. growth 66.10%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 621.60%
Op. margin 855.64%
Gross margin 367.72%
Quality
2 /100
Poor Asset turnover 0.16x
ROA 105.32%
ROIC 218.71%
Debt
66 /100
Moderate Current ratio 1.77x
Int. coverage -858.22x
Debt/Equity 0.00x
Stability
16 /100
Unstable Profitable years 0
EPS volatility 14,727.89%
Beta 1.23x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OSL.AX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Nigel Lange
Employees
6
Headquarters
Macquarie Park
Upcoming events
02 MAR
Earnings
Upcoming earnings report